机构

• 合肥物质科学研究院 [73]
• 自动化研究所 [26]
• 上海药物研究所 [11]
• 近代物理研究所 [5]
• 上海营养与健康研究所 [3]
• 上海生物化学与细胞生... [2]
• 更多

采集方式

• OAI收割 [130]
• iSwitch采集 [1]

内容类型

• 期刊论文 [128]
• 会议论文 [3]

发表日期

• 2023 [6]
• 2022 [30]
• 2021 [25]
• 2020 [28]
• 2019 [8]
• 2018 [8]
• 更多

学科主题

• Cell Biolo... [2]
• Oncology [2]
• Cell Biolo... [1]

筛选

浏览/检索结果: 共131条，第1-10条 帮助 条数/页： 5101520253035404550556065707580859095100 排序方式： 请选择提交时间升序提交时间降序发表日期升序发表日期降序题名升序题名降序作者升序作者降序 Original Research Response to programmed cell death protein 1 antibody in patients with Epstein-Barr virus-associated intrahepatic cholangiocarcinoma 期刊论文  OAI收割 EUROPEAN JOURNAL OF CANCER, 2023, 卷号: 194, 页码: 9 作者:  He, Wen-Zhuo;  Huang, Yu-Hua;  Hu, Wan-Ming;  Wang, Fang;  Xu, Yu-Xia   |  收藏  |  浏览/下载：10/0  |  提交时间：2023/12/11 Epstein-Barr virus  Intrahepatic cholangiocarcinoma  Programmed cell death protein 1  Immunotherapy   Improved clinical outcomes in advanced hepatocellular carcinoma treated with transarterial chemoembolization plus atezolizumab and bevacizumab: a bicentric retrospective study 期刊论文  OAI收割 BMC CANCER, 2023, 卷号: 23 作者:  Cao, Fei;  Shi, Changsheng;  Zhang, Guofu;  Luo, Jun;  Zheng, Jiaping   |  收藏  |  浏览/下载：9/0  |  提交时间：2023/11/10 Hepatocellular carcinoma  Atezolizumab  Bevacizumab  Overall survival  Progression-free survival   Treating relapsed/refractory mature T- and NK-cell neoplasms with tislelizumab: a multicenter open-label phase 2 study 期刊论文  OAI收割 BLOOD ADVANCES, 2023, 卷号: 7 作者:  Bachy, Emmanuel;  Savage, Kerry J.;  Huang, Huiqiang;  Kwong, Yok-Lam;  Gritti, Giuseppe   |  收藏  |  浏览/下载：17/0  |  提交时间：2023/11/10 Combining gut microbiota modulation and chemotherapy by capecitabine-loaded prebiotic nanoparticle improves colorectal cancer therapy 期刊论文  OAI收割 NATURE COMMUNICATIONS, 2023, 卷号: 14, 期号: 1, 页码: 16 作者:  Lang, Tianqun;  Zhu, Runqi;  Zhu, Xiao;  Yan, Wenlu;  Li, Yu   |  收藏  |  浏览/下载：12/0  |  提交时间：2023/10/17 SYK-mediated epithelial cell state is associated with response to c-Met inhibitors in c-Met-overexpressing lung cancer 期刊论文  OAI收割 SIGNAL TRANSDUCTION AND TARGETED THERAPY, 2023, 卷号: 8, 期号: 1, 页码: 13 作者:  Zhou, Ji;  Zhang, Xu-Chao;  Xue, Shan;  Dai, Mengdi;  Wang, Yueliang   |  收藏  |  浏览/下载：12/0  |  提交时间：2023/10/17 Small RNA sequencing identified miR-3180 as a potential prognostic biomarker for Chinese hepatocellular carcinoma patients 期刊论文  OAI收割 Frontiers in Genetics, 2023, 卷号: 14 作者:  Libo Sun;  Hansheng Zhou;  Xiaofei Zhao;  Haitao Zhang;  Yan Wang   |  收藏  |  浏览/下载：9/0  |  提交时间：2023/06/25 miRNA,  hepatocellular carcinoma  prognostic biomarker  overall survival  progression-free survival   Analysis of the efficacy and safety of immunotherapy in advanced thymoma patients 期刊论文  OAI收割 CANCER MEDICINE, 2022 作者:  Hao, Yue;  Lin, Gen;  Xiang, Jing   |  收藏  |  浏览/下载：22/0  |  提交时间：2022/12/23 efficacy  immune-related adverse events  immunotherapy  thymoma   Cost-effectiveness analysis of drug-eluting beads and conventional transarterial chemoembolization in the treatment of hepatocellular carcinoma 期刊论文  OAI收割 FRONTIERS IN PUBLIC HEALTH, 2022, 卷号: 10 作者:  Shao, Guoliang;  Wang, Jingwen;  Zhou, Xiaoying;  Sun, Guojun;  Dong, Zuojun   |  收藏  |  浏览/下载：25/0  |  提交时间：2022/12/23 DEB-TACE  cTACE  partition survival model  cost-effectiveness analysis  hepatocellular carcinoma   Whether individualized dose escalation should be recommended for lymph nodes with different sizes in the definitive radiotherapy of cervical cancer? 期刊论文  OAI收割 RADIATION ONCOLOGY, 2022, 卷号: 17 作者:  Lv, Xiaojuan;  Rao, Huiting;  Feng, Tao;  Wu, Chufan;  Lou, Hanmei   |  收藏  |  浏览/下载：24/0  |  提交时间：2022/12/22 Radiotherapy  Dose escalation  Lymph node  Uterine cervical neoplasms   Treatment outcomes and prognosis of immune checkpoint inhibitors therapy in patients with advanced thymic carcinoma: A multicentre retrospective study 期刊论文  OAI收割 EUROPEAN JOURNAL OF CANCER, 2022, 卷号: 174 作者:  Wang, Wenxian;  Lin, Gen;  Guan, Yelan;  Zhang, Yuxin;  Xu, Chunwei   |  收藏  |  浏览/下载：25/0  |  提交时间：2022/12/23 Thymic carcinoma  Immunotherapy  PD-1  Efficacy  Immune-related adverse events